Biotechnology
American VC firm Arch launches $3bn biomedical fund with eye on Japan
Fund looks to help develop startups short on capital, co-founder says
Global supplies shortage and dependence on West spell urgency, opportunity
Company aims to cut drug development time and costs by replacing animal testing
Thai group partners with Marubeni to build new pillar for growth
Southeast Asia's largest lender deals with regulator's wrath over service outage
Australia's Cortical Labs is working on 'holy grail' of AI: general intelligence
Startups see strong growth but still lag behind overseas peers
Singapore state investor wants regulatory clarity as Didi, others face scrutiny
10x Genomics opens Asia headquarters in city-state, supporting COVID-19 research
Critics take aim at nutrient-enriched Golden Rice, but government says it is safe
Threat of US sanctions clouds outlook for China's BGI
Company's COVID test kit success attracts investors amid hot local IPO market
Study indicates only modest decrease in response compared to original strain
Fresh funds to finance clinical trials and production of vaccine candidate
State issues permits to grow genetically modified corn to ensure food security
Company targets up to 3bn shots in 2022, doubling its previous forecast
Hang Seng Index overhaul to boost tech weighting and reduce financials
Japan's Susumu Shimoyama brings scientific development of latest drug to life
Money flows into health care and digital transformation-related sectors
DCI Partners targets Japan and Taiwan biotech startups developing COVID remedies
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.